Methods for modulating mannose content of recombinant proteins
OwnerJian Wu, Nicole Le +2inventors
InventorsJian Wu, Nicole Le, Michael De La Cruz, Gregory Flynn
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods of modulating (e.g., reducing) the mannose content, particularly high-mannose content of recombinant glycoproteins.
Claims42
A method of producing a composition of recombinant glycoprotein having low-mannose content comprising culturing a host-cell which expresses the recombinant glycoprotein in a culture medium having an osmolality of about 600 mOsm/Kg or less.
A method of producing a composition of recombinant antibody, or an antigen-binding fragment thereof, having low-mannose content comprising culturing a host-cell which expresses the recombinant antibody or antigen-binding fragment thereof in a culture medium having an osmolality of about 600 mOsm/Kg or less.
A method of producing a composition of recombinant human monoclonal antibody, or antigen-binding fragment thereof, that binds IL-15, comprising culturing a host-cell which expresses the antibody or antigen-binding fragment thereof in a culture medium having an osmolality of about 600 mOsm/Kg or less, wherein the antibody or antigen-binding fragment thereof comprises a light chain variable region comprising the amino acid sequence set forth in SEQ ID NO:4, or conservative amino acid substitutions thereof, and a heavy chain variable region comprising the amino acid sequence set forth in SEQ ID NO:2, or conservative amino acid substitutions thereof.
A composition comprising an isolated antibody or an antigen-binding fragment thereof having low-mannose content.
A composition comprising an isolated human monoclonal antibody that binds IL-15, or an antigen-binding fragment thereof, having low-mannose content.
A composition of a human monoclonal antibody having low-mannose content, said antibody comprising a light chain variable region comprising the amino acid sequence set forth in SEQ ID NO:4, or an amino acid sequence of at least 90% or at least 95% identity thereto, or conservative amino acid substitutions thereof, and a heavy chain variable region comprising the amino acid sequence set forth in SEQ ID NO:2, or an amino acid sequence of at least 90% or at least 95% identity thereto, or conservative amino acid substitutions thereof.
A composition of a human monoclonal antibody having low-mannose content, said antibody comprising a light chain variable region comprising one or more CDRs comprising amino acid sequences set forth in SEQ ID NOs:8-10, or an amino acid sequence of at least 90% or at least 95% identity thereto, or conservative amino acid substitutions thereof, and a heavy chain variable region comprising one or more CDRs comprising amino acid sequences set forth in SEQ ID NOs:5-7, or an amino acid sequence of at least 90% or at least 95% identity thereto, or conservative amino acid substitutions thereof.
A method of detecting and/or quantitating the high-mannose content of a glycoprotein in a sample, said method comprising subjecting said sample to an endoglycosidase digestion followed by separating the digested glycoproteins by electrophoresis.
Dependencies are inferred from the claim text.